US states claim $2.2trn in opioid compensation from Purdue Pharma

Forty-nine US states and several territories are suing Purdue Pharma LP for a combined total of $2.2trillion for its role in the opioid crisis in the US. The claim is based on allegations that Purdue Pharma LP encouraged physicians to prescribe opioid painkillers and that they diminished the risks of abuse and overdose. Purdue Pharma LP filed for bankruptcy in 2019 following 2,600 lawsuits bought by a range of US cities, counties, states and other groups. The company denies the allegations.